Sequestration of carbon dioxide with hydrogen to useful products

US9587256B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9587256-B2
Application numberUS-201314426290-A
CountryUS
Kind codeB2
Filing dateSep 6, 2013
Priority dateSep 6, 2012
Publication dateMar 7, 2017
Grant dateMar 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are genetically engineered microbes that include at least a portion of a carbon fixation pathway, and in one embodiment, use molecular hydrogen to drive carbon dioxide fixation. In one embodiment, the genetically engineered microbe is modified to convert acetyl CoA, molecular hydrogen, and carbon dioxide to 3-hydroxypropionate, 4-hydroxybutyrate, acetyl CoA, or the combination thereof at levels greater than a control microbe. Other products may also be produced. Also provided herein are cell free compositions that convert acetyl CoA, molecular hydrogen, and carbon dioxide to 3-hydroxypropionate, 4-hydroxybutyrate, acetyl CoA, or the combination thereof. Also provided herein are methods of using the genetically engineered microbes and the cell free compositions.

First claim

Opening claim text (preview).

What is claimed is: 1. A genetically engineered microbe modified to convert acetyl CoA, molecular hydrogen, and carbon dioxide to 3-hydroxypropionate, wherein the 3-hydroxypropionate is produced at an increased level compared to a control microbe, wherein the microbe is a hyperthermophile, wherein the microbe is a member of the domain Archaea or a member of the domain Bacteria, and wherein the microbe comprises an exogenous coding region encoding a polypeptide, wherein the polypeptide has an activity selected from acetyl/propionyl-CoA carboxylase activity, malonyl/succinyl-CoA reductase activity, and malonate semialdehyde reductase activity. 2. The genetically engineered microbe of claim 1 wherein the hyperthermophile is a member of the Order Thermococcales, a member of the Order Sulfolobales, or a member of the Order Thermotogales. 3. The genetically engineered microbe of claim 1 wherein the microbe further comprises a NADPH-dependent hydrogenase. 4. The genetically engineered microbe of claim 1 wherein the microbe comprises exogenous coding regions encoding subunits of the NADPH-dependent hydrogenase. 5. The genetically engineered microbe of claim 1 wherein the exogenous coding region is operably linked to a temperature sensitive promoter, to a constitutive promoter, or to a non-regulated promoter. 6. The genetically engineered microbe of claim 2 wherein the hyperthermophile is Thermococcus kodakarensis, T. onnurineus, Sulfolobus solfataricus, S. islandicus, S. Acidocaldarius , or Pyrococcus furiosus. 7. The genetically engineered microbe of claim 1 wherein the hyperthermophile is a Caldicellulosiruptor spp. 8. The genetically engineered microbe of claim 7 wherein the Caldicellulosiruptor is C. bescii. 9. A method comprising incubating the genetically engineered microbe of claim 1 under anaerobic conditions suitable for converting acetyl CoA, molecular hydrogen, and carbon dioxide to 3-hydroxypropionate. 10. The method of claim 9 further comprising recovering the 3-hydroxypropionate.

Assignees

Inventors

Classifications

  • 3-Hydroxypropionyl-CoA synthase (6.2.1.36) · CPC title

  • Methylmalonyl-CoA mutase (5.4.99.2) · CPC title

  • Methylmalonyl-CoA epimerase (5.1.99.1) · CPC title

  • 3-Hydroxypropionyl-CoA dehydratase (4.2.1.116) · CPC title

  • Acrylyl-CoA reductase (NADH) (1.3.1.95) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9587256B2 cover?
Provided herein are genetically engineered microbes that include at least a portion of a carbon fixation pathway, and in one embodiment, use molecular hydrogen to drive carbon dioxide fixation. In one embodiment, the genetically engineered microbe is modified to convert acetyl CoA, molecular hydrogen, and carbon dioxide to 3-hydroxypropionate, 4-hydroxybutyrate, acetyl CoA, or the combination t…
Who is the assignee on this patent?
Univ Georgia, Univ North Carolina State
What technology area does this patent fall under?
Primary CPC classification C12P7/42. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).